Cablegate: Spanish Component of U.S./Fda Orphan Product

VZCZCXYZ0001
RR RUEHWEB

DE RUEHMD #0497 0750755
ZNR UUUUU ZZH
R 160755Z MAR 07
FM AMEMBASSY MADRID
TO RUEHC/SECSTATE WASHDC 2101
INFO RUEHRL/AMEMBASSY BERLIN 0611
RUEHBY/AMEMBASSY CANBERRA 0855
RUEHLO/AMEMBASSY LONDON 0867
RUEHOT/AMEMBASSY OTTAWA 2738
RUEAUSA/DEPT OF HHS WASHDC

UNCLAS MADRID 000497

SIPDIS

SIPDIS

HHS PASS TO FDA OFFICE OF INTERNATIONAL PROGRAMS (ELAINE
FOSTER)

E.O. 12958: N/A
TAGS: TBIO OTRA TPHY KSCA SP
SUBJECT: SPANISH COMPONENT OF U.S./FDA ORPHAN PRODUCT
DEVELOPMENT GRANT AWARD

REF: SECSTATE 30378

Embassy Madrid is aware of no concerns or objections
regarding the foreign policy implications of reftel grant.
Embassy checked with the two Spanish institutions listed as
participating in the grant award. Dr. Justo Garcia de
Yebenes of the Ramon and Cajal Hospital confirmed that he
leads a team that will work on this project. However, Dr.
Asuncion Martinez of the Jimenez Diaz Foundation indicated
that her foundation would not participate. She indicated
that she understood that Dr. de Yebenes of the Ramon and
Cajal Hospital would participate in the project.
Llorens

© Scoop Media